Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Boman E et al. |
Treatment accuracy without rotational setup corrections in intracranial SRT.
|
|
2 |
Boman E et al. |
A new split arc VMAT technique for lymph node positive breast cancer.
|
|
3 |
Hakala T et al. |
Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.
|
|
4 |
Hietanen T et al. |
Restoring Natural Killer Cell Cytotoxicity After Hyperthermia Alone or Combined with Radiotherapy.
|
|
5 |
Hietanen T et al. |
Post-irradiation viability and cytotoxicity of natural killer cells isolated from human peripheral blood using different methods.
|
|
6 |
Joensuu T et al. |
Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation.
|
|
7 |
Kapanen M et al. |
Residual position errors of lymph node surrogates in breast cancer adjuvant radiotherapy: Comparison of two arm fixation devices and the effect of arm position correction.
|
|
8 |
Kaukonen R et al. |
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription.
|
|
9 |
Kellokumpu-Lehtinen P-L, Bono P. |
Immuno-onkologian esiinmarssi.
|
|
10 |
Lampinen A et al. |
Novel Angiogenesis Markers as Long-Term Prognostic Factors in Patients With Renal Cell Cancer.
|
|
11 |
Leskelä R et al. |
Syöpätautien hoitokäytännöt ja resursointi yliopistosairaaloissa vertaiskehittämisen avulla arvioituna.
|
|
12 |
Luhtala S et al. |
Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
|
|
13 |
Mittal D et al. |
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.
|
|
14 |
Ojala J et al. |
Full Monte Carlo and measurement-based overall performance assessment of improved clinical implementation of eMC algorithm with emphasis on lower energy range.
|
|
15 |
Rajala K et al. |
End-of-life care of patients with idiopathic pulmonary fibrosis.
|
|
16 |
Roine E et al. |
Health-related Quality of Life in Breast Cancer Patients after Adjuvant Treatments.
|
|
17 |
Rossi M et al. |
A novel arc geometry setting for pelvic radiotherapy with extensive nodal involvement.
|
|
18 |
Sipilä P et al. |
Gafchromic EBT3 film dosimetry in electron beams - energy dependence and improved film read-out.
|
|
19 |
Skyttä T et al. |
Improving the reproducibility of voluntary deep inspiration breath hold technique during adjuvant left-sided breast cancer radiotherapy.
|
|
20 |
Skyttä Tanja. |
Cardiotoxicity of adjuvant breast cancer radiotherapy.
|
|
21 |
Sormunen J et al. |
Perceived physical strain at work and incidence of colorectal cancer: A nested case–control study.
|
|
22 |
Sunela K, Bärlund M. |
Ifosfamidin aiheuttama enkefalopatia.
|
|
23 |
Tiainen L et al. |
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
|
|
24 |
Tuohinen SS et al. |
Detection of radiotherapy-induced myocardial changes by ultrasound tissue characterisation in patients with breast cancer.
|
|
25 |
Valtola J et al. |
Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.
|
|
26 |
Vanhanen A, Kapanen M. |
The effect of rectal retractor on intrafraction motion of the prostate.
|
|
27 |
Virman J. |
Renal cell carcinoma and long-term prognostic factors.
|
|
28 |
Virman J et al. |
Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer.
|
|
29 |
Wirtz RM et al. |
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
|
|
30 |
Wu X et al. |
Differentiation of Diffuse Large B-cell Lymphoma From Follicular Lymphoma Using Texture Analysis on Conventional MR Images at 3.0 Tesla.
|